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patients. Patients were referred for interventional catheterization
(n = 12, 17.6%), for surgery (n = 5, 7.4%), for acute heart failure
(n = 3, 4.4%, 100% type C) or for medical follow-up. Complications
[stroke (n = 2/12), heart failure (n = 10/12), arrhythmia (n = 7/12),
pulmonary hypertension (n = 5/12), death (n = 1/12)] were mainly
observed in C patients (P = 0.018). C and M patients had lower edu-
cation level (respectively 14.3%, 12.5% vs. 55.7% had Baccalaureat,
P = 0.019). C patients had less access to driving license (P = 0.02).
Only 1/3 of C patients had an active employment. Physical activity
was lower in C patients (P = 0.02, none activity in 87.5% but 57%
had been previously contra-indicated to sport). There was no
signiﬁcant difference between the three groups regarding antide-
pressant medication (8.2%, P = 0.578), psychological follow-up
(19.0%).
Conclusion.— ACHD patients with complex heart disease have
reached adulthood as survivors. Their medical past has impacted
their social development and professional activity. Speciﬁc atten-
tion should be paid to the schooling of children with complex
congenital heart disease.
http://dx.doi.org/10.1016/j.acvd.2013.06.026
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Introduction.— Very few comparative studies have yet reported
health related quality of life (HRQoL) among children with congen-
ital heart diseases (CHD).
Method.— We prospectively recruited children aged 8 to 18 with
CHD (group 1, n = 282) and same age randomized control popula-
tion selected among schools (group 2, n = 164). CHD were recruited
in two tertiary care centers in France and Belgium. Thirty fami-
lies refused to participate in group 1 and 150 in group 2. Primary
outcome was the scoring for each dimension with Kidscreen-52 for
children and Kidscreen-27 for parents (French version of the generic
validated pediatric HRQoL questionnaire). Secondary outcomes
were: severity class of CHD from 1 to 4 (from Uzark), cardiopul-
monary exercise test (VO2max, anaerobic threshold, VE/VCO2 slope,
oxygen uptake efﬁciency slope), and PedsQL scoring (non-validated
HRQoL generic questionnaire, French and Belgium versions, self and
parents reports).
Results.— Two hundred and eighty-two children with CHD (sex
ratio 1.9 — mean age 12.3± 3) and 164 children in schools (sex-
ratio 1.1 — mean age 12.8± 2.4) were recruited. Both centers
were comparable for most demographic and clinical data. In most
dimensions self-reported QoL scores among children with CHD were
not different from control group, except for physical well-being
(mean 46.5± 10.2 vs. 49.9± 8.6, P < 0.05). QoL in lower sever-
ity classes was not signiﬁcantly different from controls. Children
with severe CHD (class 4) had lower QoL in physical well-being
(43.34± 9.64, P < 0.05). In group 1, parents’ reported QoL was lower
than their children’s evaluation in several dimensions (physical,
social, school). In control group, scores between self-reported and
parents reported QoL were identical. Teenagers had higher QoL
scores than younger children. Cardiopulmonary exercise test is well
correlated to HRQoL, especially for well-being dimension.
Conclusion.— QoL among children with CHD is close to that of same
age healthy children except for physical well-being. HRQoL for low
severity CHD patients is similar to controls. QoL for severe CHD is
the most impacted. Further studies should evaluate QoL evolution
in time per patient.
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